Cargando…
Dyslipidemia and Meibomian Gland Dysfunction: Utility of Lipidomics and Experimental Prospects with a Diet-Induced Obesity Mouse Model
Meibomian gland dysfunction (MGD) is the leading cause of dry eye disease and loss of ocular surface homeostasis. Increasingly, several observational clinical studies suggest that dyslipidemia (elevated blood cholesterol, triglyceride or lipoprotein levels) can initiate the development of MGD. Howev...
Autores principales: | Osae, Eugene A., Steven, Philipp, Redfern, Rachel, Hanlon, Samuel, Smith, C. Wayne, Rumbaut, Rolando E., Burns, Alan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678820/ https://www.ncbi.nlm.nih.gov/pubmed/31319467 http://dx.doi.org/10.3390/ijms20143505 |
Ejemplares similares
-
Obese Mice with Dyslipidemia Exhibit Meibomian Gland Hypertrophy and Alterations in Meibum Composition and Aqueous Tear Production
por: Osae, Eugene A., et al.
Publicado: (2020) -
Meibomian Gland Dysfunction in Ocular Graft vs. Host Disease: A Need for Pre-Clinical Models and Deeper Insights
por: Appenteng Osae, Eugene, et al.
Publicado: (2021) -
Association of the severity of meibomian gland dysfunction with dyslipidemia in Indian population
por: Guliani, Brahm P, et al.
Publicado: (2018) -
Dyslipidemia Exacerbates Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis
por: Tomioka, Yasufumi, et al.
Publicado: (2023) -
Assessment of meibomian glands using a custom–made meibographer in dry eye patients in Ghana
por: Osae, Eugene Appenteng, et al.
Publicado: (2018)